Latest AvidBiotics Corp. Stories
Modified MIC Proteins as Targeted Immunotherapy for Cancer and Virus-Infected Cells SOUTH SAN FRANCISCO, Calif., March 25, 2014 /PRNewswire/ -- AvidBiotics Corp., a privately held
Novel Agents Selectively Targeting an Intestinal Pathogen and Increasing Threat to Human and Animal Health SOUTH SAN FRANCISCO, March 19, 2014 /PRNewswire/ -- AvidBiotics Corp., a
SOUTH SAN FRANCISCO, Calif. and ST. PAUL, Minn., Jan. 11 /PRNewswire/ -- AvidBiotics Corp. and Ecolab Inc. today announced an agreement under which they will work to develop a new technology to dramatically reduce the presence of the dangerous pathogen E.
SOUTH SAN FRANCSICO, Calif., Nov. 12 /PRNewswire/ -- AvidBiotics Corp. announced the issuance of foundational patents encompassing a completely novel mechanism for generating massive diversity within precisely targeted sites of protein-encoding DNA sequences.
- A volcanic mudflow.